Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,206 | 213,645 | 101,136 | 57,841 | 125,166 |
| Marketable Securities | 333,523 | 211,093 | 53,153 | 63,001 | 16,107 |
| Other current assets | 0 | 0 | 300,000 | 0 | 0 |
| TOTAL | $400,066 | $429,824 | $459,562 | $123,953 | $144,672 |
| Non-Current Assets | |||||
| PPE Net | 16,459 | 16,943 | 17,563 | 18,346 | 19,002 |
| Other Non-Current Assets | 40,375 | 41,538 | 42,649 | 43,770 | 44,852 |
| TOTAL | $56,834 | $58,481 | $60,212 | $62,116 | $63,854 |
| Total Assets | $456,900 | $488,305 | $519,774 | $186,069 | $208,526 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,635 | 5,071 | 3,819 | 3,821 | 3,406 |
| Accrued Expenses | 8,096 | 7,010 | 9,562 | 7,206 | 5,152 |
| TOTAL | $47,965 | $48,243 | $48,692 | $19,296 | $16,414 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 19,914 | 19,826 |
| Deferred Revenues | 30,565 | 30,059 | 28,317 | 1,278 | 910 |
| Other Non-Current Liabilities | 49,231 | 50,593 | 51,481 | 53,191 | 54,803 |
| TOTAL | $361,303 | $367,661 | $374,211 | $85,791 | $87,922 |
| Total Liabilities | $409,268 | $415,904 | $422,903 | $105,087 | $104,336 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,637 | 41,468 | 41,422 | 37,092 | 36,937 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -318,483 | -291,170 | -264,256 | -235,113 | -209,033 |
| Other shareholders' equity | -3,189 | -1,194 | -10 | -13 | -10 |
| TOTAL | $47,632 | $72,401 | $96,871 | $80,982 | $104,190 |
| Total Liabilities And Equity | $456,900 | $488,305 | $519,774 | $186,069 | $208,526 |